|
|
|
| home > epc > Autumn 2017 |
|
|
 PUBLICATIONS |
 |
|
|
 |
News and Press Releases |
 |
Phenomenex Introduces bioZen Series for Characterization of Biotherapeutics
Torrance, Calif. (April 16, 2018) – Phenomenex Inc., a global leader in
the research and manufacture of advanced technologies for the separation
sciences, introduces bioZen – a new series of LC solutions for bioseparations
in pharmaceutical, biopharmaceutical and academic research. The series
encompasses both proven and entirely new media spanning two particle platforms
– core-shell and thermally modified fully porous – along with new biocompatible
titanium hardware. The initial bioZen product line features seven chemistries
for the UHPLC and HPLC characterization of biotherapeutics such as monoclonal
antibodies, antibody-drug conjugates and biosimilars. The offering includes
specific LC chemistries for the analysis of aggregates and total mAb, intact
mass and fragments, peptide mapping and quantitation and glycan mapping.
More info >> |
|
 |
White Papers |
 |
|
Successfully managing the unique demands of cell therapy supply chains
PCI Pharma Services
Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >> |
|
 |
Industry Events |
 |
SMi presents the 13th Conference on ADMET
9-10 July 2018, Holiday Inn Kensington Forum, London, UK
SMi is delighted to announce the 13th annual ADMET
conference returning to London to explore the optimisation of ADMET modelling techniques, preclinical
DMPK applications and development of biopharmaceuticals.
More info >> |
|
|
